nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An update from the 2019 ESMO meeting
|
Pircher, Andreas |
|
|
13 |
2 |
p. 139-140 |
artikel |
2 |
Circumnavigating the challenges of COVID-19 in oncology
|
Fuereder, Thorsten |
|
|
13 |
2 |
p. 135-138 |
artikel |
3 |
Current state and perspectives of checkpoint inhibitors in ovarian cancer treatment
|
Bartl, Thomas |
|
|
13 |
2 |
p. 202-206 |
artikel |
4 |
Diagnostic and therapeutic management of sarcoma patients
|
Seeber, Andreas |
|
|
13 |
2 |
p. 141-142 |
artikel |
5 |
Different CALR mutation subtypes in essential thrombocythemia and primary myelofibrosis patients without JAK2 mutation
|
Saleh, Layla M. |
|
|
13 |
2 |
p. 235-243 |
artikel |
6 |
Epithelial ovarian cancer
|
Reinthaller, Alexander |
|
|
13 |
2 |
p. 143-144 |
artikel |
7 |
ESMO 2019: breast cancer
|
Bartsch, Rupert |
|
|
13 |
2 |
p. 147-149 |
artikel |
8 |
ESMO 2019—personal highlights in gastrointestinal cancer
|
Amann, A. |
|
|
13 |
2 |
p. 154-156 |
artikel |
9 |
ESMO 2019—personal non-small lung cancer highlights
|
Horvath, Lena |
|
|
13 |
2 |
p. 150-153 |
artikel |
10 |
Hepatocellular carcinoma
|
Djanani, Angela |
|
|
13 |
2 |
p. 145-146 |
artikel |
11 |
Immunotherapy in hepatocellular carcinoma
|
Hametner-Schreil, Stephanie |
|
|
13 |
2 |
p. 218-222 |
artikel |
12 |
Metastatic sarcoma: tailored strategies for a heterogeneous disease
|
Grassi, Massimiliano |
|
|
13 |
2 |
p. 179-184 |
artikel |
13 |
My personal highlights of ESMO 2019 regarding urogenital cancer
|
Niedersüß-Beke, Dora |
|
|
13 |
2 |
p. 157-158 |
artikel |
14 |
Ovarian cancer surgery
|
Schwameis, Richard |
|
|
13 |
2 |
p. 193-197 |
artikel |
15 |
PARP inhibitors in the treatment of ovarian cancer
|
Zeimet, Alain G. |
|
|
13 |
2 |
p. 198-201 |
artikel |
16 |
Perioperative treatment of soft-tissue sarcoma
|
Rothermundt, Christian |
|
|
13 |
2 |
p. 174-178 |
artikel |
17 |
PLATON: use of romiplostim to treat chronic primary immune thrombocytopenia
|
Mihaylov, Georgi |
|
|
13 |
2 |
p. 227-234 |
artikel |
18 |
Radiotherapy in soft tissue sarcoma
|
Röder, Falk |
|
|
13 |
2 |
p. 169-173 |
artikel |
19 |
Screening for ovarian cancer: is there still hope?
|
Aust, Stefanie |
|
|
13 |
2 |
p. 189-192 |
artikel |
20 |
Systemic therapy in advanced-stage hepatocellular carcinoma
|
Graziadei, Ivo |
|
|
13 |
2 |
p. 212-217 |
artikel |
21 |
The intestinal microbiota and hepatocellular carcinoma
|
Effenberger, Maria |
|
|
13 |
2 |
p. 223-226 |
artikel |
22 |
Therapy management in bone sarcoma
|
Thaler, Martin |
|
|
13 |
2 |
p. 185-188 |
artikel |
23 |
Thermal ablation—an option in curative treatment of HCC
|
Putzer, Daniel |
|
|
13 |
2 |
p. 207-211 |
artikel |
24 |
The role of pathology in sarcoma
|
Liegl-Atzwanger, Bernadette |
|
|
13 |
2 |
p. 159-163 |
artikel |
25 |
The role of surgery in soft tissue sarcoma: Can we improve outcome and function towards sporting activities?
|
Windhager, Reinhard |
|
|
13 |
2 |
p. 164-168 |
artikel |